Sartorius Stedim Biotech S.A.

SRTOY | OTC

Price Alert Chart Builder DCF Calculator

$24.81

-$0.51 (-2.01%)

At close: Oct 30, 2026, 3:58 PM ET

$24.81

$0.00 (0.00%)

After-hours: Oct 30, 2026, 4:00 PM ET

Overview Rating Statistics Financials Earnings Ownership Dividends Profile

Market Data

Market Cap $241.38B

Enterprise Value $215.2B

Beta 1.14

Average Volume 24.1K

Shares Outstanding (Diluted) 97.3M

Shares Change YoY 0%

Institutional Ownership N/A

Exchange OTC

ISIN US80386Y1010

Price Performance

Price Change 1M -2.7%

Price Change 3M 29.5%

Price Change 6M 38.0%

Price Change YTD 4.4%

Price Change 1Y 1.3%

Price Change 3Y 49.7%

Price Change 5Y N/A

1M CAGR (ann.) 9.8%

1Y CAGR (ann.) 1.5%

5Y CAGR (ann.) N/A

All-Time CAGR -10.9%

Valuation

PE Ratio 6.39

Forward PE N/A

PEG Ratio 2.82

Forward PEG 5.08

PS Ratio 67.86

Forward PS 61.60

PB Ratio 48.67

P/FCF Ratio 770.90

P/Adj. FCF Ratio 770.90

P/OCF Ratio 3.36

EV/Sales 70.29

EV/EBIT 374.58

EV/EBITDA 238.92

EV/FCF 798.50

Earnings Yield 15.1%

FCF Yield 0.1%

Adj. FCF Yield 0.1%

Financial Health

Net Debt €1.99B

Total Debt €2.31B

Cash & Short-Term Investments €172M

Total Assets €8.04B

Current Ratio 1.22

Quick Ratio 0.57

Debt / Equity Ratio 0.53

Debt / EBITDA 2.57

Debt / FCF 8.57

OCF / Debt 0.27

Interest Coverage 3.78

Altman Z-Score 36.21

Piotroski F-Score 7

Margins & Profitability

Gross Profit Margin 44.5%

Operating Profit Margin 19.4%

EBITDA Margin 29.4%

Net Profit Margin 10.6%

FCF Margin 8.8%

Adj. FCF Margin 8.8%

SBC / Revenue 0.0%

SBC Impact (per share) N/A

Returns

Return on Assets 4.0%

Return on Equity 7.7%

Return on Invested Capital 6.0%

Return on Capital Employed 8.6%

Return on Tangible Assets 8.8%

Historical Growth (CAGR)

Revenue CAGR 3Y 1.1%

Revenue CAGR 5Y 3.0%

Revenue CAGR 10Y 11.7%

EPS CAGR 3Y -12.3%

EPS CAGR 5Y -10.5%

EPS CAGR 10Y 7.8%

FCF CAGR 3Y 31.9%

FCF CAGR 5Y -5.5%

FCF CAGR 10Y 13.6%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Jan 26, 2026

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) $865.18M

Revenue Growth Est (next Q) -1.0%

Fair Value Estimates

Graham Number $65.97

Graham Upside 165.9%

Lynch Fair Value $19.40

Lynch Upside -21.8%

Price Target $0.00

Price Target Upside N/A

Cash Flow

Operating Cash Flow €618.5M

Free Cash Flow €269.5M

Adj. Free Cash Flow €269.5M

FCF Per Share $2.77

OCF Per Share $6.36

OCF/S Ratio 20.2%

Income Statement

Revenue €3.06B

Gross Profit €1.36B

Operating Income €592.8M

EBITDA €900.7M

Net Income €323.9M

EPS (Diluted) $3.34

Revenue / Employee $298.25K

Profit / Employee $31.55K

Employees 10,265

Dividends

Annual Dividend $0.08

Dividend Yield 0.32%

Payout Ratio 2.5%

FCF Payout Ratio 24.9%

Adj. FCF Payout Ratio 24.9%

Dividend Growth (YoY) 8.1%

Pay Frequency Annual

Ex-Dividend Date Apr 1, 2026